Protein Knockdown Technology: Application of Ubiquitin Ligase to Cancer Therapy

E-ISSN： 1873-5576|16|2|136-146

ISSN： 1568-0096

Source： Current Cancer Drug Targets, Vol.16, Iss.2, 2016-02, pp. : 136-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the ubiquitin-proteasome system for cancer therapy

By Shen Min

Expert Opinion on Therapeutic Targets, Vol. 17, Iss. 9, 2013-09 ,pp. : 1091-1108

Informa Healthcare

Access to resources Recommend Favorite

Targeting the Ubiquitin-Proteasome Pathway: An Emerging Concept in Cancer Therapy

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 23, 2011-12 ,pp. : 2888-2905

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Ubiquitin-Mediated Proteasome Degradation of p53 for Cancer Therapy

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3248-3262

Bentham Science Publishers

Access to resources Recommend Favorite

Editorial (The Ubiquitin Proteasome System as a Source of Drug Targets for Cancer Therapy)

Current Pharmaceutical Design, Vol. 19, Iss. 22, 2013-07 ,pp. : 4024-4024

Bentham Science Publishers

Access to resources Recommend Favorite

Pharmaceutical Perspectives of HECT-TYPE Ubiquitin Ligase Smurf1

Current Pharmaceutical Design, Vol. 19, Iss. 18, 2013-06 ,pp. : 3226-3233

Bentham Science Publishers

Access to resources Recommend Favorite